2022
Proteasomal degradation within endocytic organelles can mediate antigen cross- presentation
Sengupta D, Graham M, Liu X, Cresswell P. Proteasomal degradation within endocytic organelles can mediate antigen cross- presentation. Molecular Immunology 2022, 150: 23. DOI: 10.1016/j.molimm.2022.05.080.Peer-Reviewed Original ResearchDendritic cellsMHC-I moleculesMouse bone marrow-derived dendritic cellsBone marrow-derived dendritic cellsMarrow-derived dendritic cellsAntigen processingConventional antigen processingMouse dendritic cellsMHC-I-peptide complexesSurface MHCMHCSurface expressionProteasome inhibitionPeptide loadingHuman B2Cell phagosomesCell typesActive proteasomesSpecific peptidesCellsPeptidesEndocytic compartmentsProteasomal degradationEndocytic pathway
2014
A congenital disorder of deglycosylation: biochemical characterization of N‐glycanase 1 deficiency in patient fibroblasts (607.3)
He P, Ng B, Cresswell P, Grotzke J, Gunel M, Jafar‐Nejad H, Kodali V, Kaufman R, Freeze H. A congenital disorder of deglycosylation: biochemical characterization of N‐glycanase 1 deficiency in patient fibroblasts (607.3). The FASEB Journal 2014, 28 DOI: 10.1096/fasebj.28.1_supplement.607.3.Peer-Reviewed Original ResearchN-glycanase 1 (NGLY1) deficiencyN-glycanase 1Patient fibroblastsMisfolded glycoproteinsER stressPatient-derived fibroblastsFree oligosaccharidesSignal transductionProteasomal degradationBiochemical characterizationNGLY1Enzymatic activitySubstrate accumulationExome sequencingPhysiological conditionsDeglycosylationFibroblastsAbnormal liver functionGlycoproteinMutationsCongenital disorderPeripheral neuropathyLiver functionAltered size distributionTransduction
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply